⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRNA News
Moderna, Inc. Common Stock
Alpha-9 Oncology Announces First Patient Dosed in Phase 1 Study of A9-3408 for the Treatment of Melanoma
prnewswire.com
DRGN
MRNA
Seasonal Vaccines Market Accelerating Growth and Rising Opportunities Through 2035
globenewswire.com
PFE
MRNA
GSK
Veeva AI Agents Now Available to Increase Productivity and Customer Centricity USA - English USA - English
prnewswire.com
VEEV
BMY
MRNA
NVO
OTK
CRNX
Veeva AI Agents Now Available to Increase Productivity and Customer Centricity USA - English USA - English
prnewswire.com
VEEV
BMY
MRNA
NVO
OTK
CRNX
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
globenewswire.com
ARKK
TSLA
AAPL
NVDA
AMZN
META
GOOGL
NFLX
COIN
MSFT
DIS
XOM
JPM
AMD
PYPL
SQ
MRNA
AI
MSTR
SNOW
ABNB
BABA
TSM
SMCI
PLTR
MARA
CVNA
HOOD
BRK.B
DKNG
RBLX
RDDT
GME
HIMS
CRCL
GDX
YQQQ
American Liver Foundation Hosts the 34th Annual Irwin M. Arias Symposium
prnewswire.com
MRNA
RNA Therapeutics and Vaccines Market to Soar USD 107.7 Billion by 2034 at Explosive 87% CAGR, Driven by Breakthrough RNA Technologies
globenewswire.com
MRNA
Respiratory Syncytial Virus Market to Reach USD 4.54 Billion by 2033 as Global Uptake of Next-Generation Vaccines & Monoclonal Antibodies Accelerates
prnewswire.com
PFE
GSK
AZN
SNY
MRK
MRNA
U.S. CAR T-Cell Therapies Market Grows at 30.4% CAGR, Soars USD 42.61 Billion by 2035
globenewswire.com
BIIB
GILD
BMY
ABBV
MRNA
CRSP
NTLA
EDIT
8MM Respiratory Syncytial Virus Prophylaxis Drug Forecast Report 2025: A $7.2 Billion Market by 2030, Prophylactic Options to Continue to Diversify Due to Strength of Late-stage Pipeline
globenewswire.com
AZN
ABBV
SNY
MRK
GSK
PFE
MRNA